A Comparative Expected Value Analysis Study to Determine If the Economic Benefits of Screening and Early Diagnosis Treatment of the Most Common Types of Cancer in the United States Provide Economic Value
Downloads
Breast, colorectal and skin cancer screening and early diagnosis with treatment provides economic value, while lung cancer screening and early diagnosis with treatment came close to providing economic value. Bladder, endometrial, kidney, leukemia, non-Hodgkin lymphoma, pancreatic, prostate and thyroid cancer screening and early diagnosis with treatment were not found to have provided economic value.
Ahern CH, Shen Y. Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines. Cancer Epidemiol Biomarkers Prev. 2009; 18 (3):718-725.
Ahlquist DA. Universal cancer screening: revolutionary, rational, and realizable. NPJ Precis Oncol. 2018; 2:23.
American Thyroid Association, Thyroid Cancer, Detecting recurrence of papillary thyroid cancer costs much more in those with low-risk than high risk cancer, Clinical Thyroidology for the Public, 2016, 9,2, 10-11
American Cancer Society: Cancer Facts and Figures, American Cancer Society, 2019
American Cancer Society, Key Statistics for Colon Cancer, 2021.
American Cancer Society. Mammograms. Revised October 3, 2019.
American Cancer Society. Cancer Facts & Figures, 2020.
Bardi J, How Prostate Cancer Therapies Compare by Cost and Effectiveness, UCSF Report, January 4, 2013
Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, Naeim A, Church TR, Silvestri GA, Gorelick J and Gatsonis, C, Cost-Effectiveness of CT Screening in the National Lung Screening Trial, N Engl J Med 2014; 371:1793-1802
Blumen H, Fitch K, Polkus V, Comparison of treatment costs for breast cancer by tumor stage and type of Service, Am Health Drug Benefits. 2016 Feb; 9(1): 23–32.
Breast Cancer Surveillance Consortium - BCSC (2017). Sensitivity, specificity, and false negative rate for 1,682,504 screening mammography examinations from 2007-2013.
Brill JV, Screening for Cancer: The Economic, Medical, and Psychosocial Issues, AJMC, November 16, 2020
Cancer.org, Can Kidney Cancer be Found Early, Cancer.org, 2020, February 1
Cancer.Org, Can Non-Hodgkin Lymphoma Be Found Early, Cancer.org, 2021
Chou R, Bladder Cancer in Adults: Screening, Ann Intern Med, 2010, 153:461-468
Clarke CA, Hubbell E, Kurian AW, Colditz GA, Hartman AR, Gomez SL. Projected reductions in absolute cancer–related deaths from diagnosing cancers before metastasis, 2006–2015. Cancer Epidemiol Biomarkers Prev. 2020; 29 (5):895-902.
Crépel M, Jeldres C, Sun M, Lughezzani G, Isbarn H, Alasker A, et al. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma. Urology (2010) 76(4):883
de Carvalho TM, Heijnsdijk EA, de Koning HJ. Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance. Cancer. 2018; 124 (3):507-513.
Eaglehouse YL, George MW, Richard P, Shriver CD, Zhu K (2019) Costs for Colon Cancer Treatment Comparing Benefit Types and Care Sources in the US Military Health System, Military Medicine, Volume 184, Issue 11-12, November-December 2019, Pages e847–e855,
Elder C, How much does breast cancer treatment cost in the US? The check up by Single Care, 2017
Esselen KM, Feldman S. Cost-effectiveness of cervical cancer prevention. Clin Obstet Gynecol. 2013; 56 (1):55-64.
Ekwueme DU, Gardner JG, Subramanian S, Tangka FK, Bapat B, Richardson LC. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004. Cancer (2008) 112(3):626
Farivar-Mohseni H, Perlmutter AE, Wilson S, Shingleton WB, Bigler SA, Fowler JE, Renal cell carcinoma and end stage renal disease, J Urol. 2006 Jun; 175(6):2018-20; discussion 2021.
Gilda TR, Byfield SD, Hogarth DK, Wilson DS, Quinn CC, A retrospective analysis of delays in the diagnosis of lung cancer and associated costs, Clinicoecon Outcomes Res, 2017; 9: 261–269.
Halpern JA, Chughtai B, Ghomrawi H. Cost-effectiveness of Common Diagnostic Approaches for Evaluation of Asymptomatic Microscopic Hematuria. JAMA Intern Med 2017; 177:800-7.
Hollenbeck BK, Ye Z, Dunn RL, Montie JE, Birkmeyer JD, Provider treatment intensity and outcomes for patients with early-stage bladder cancer. J Natl Cancer Inst. 2009; 101: 571-580
Howlader N, Noone A, Krapcho M. editors. SEER Cancer Statistics Review. National Cancer Institute; (1975–2009)
Islami F, Miller KD, Siegel RL, et al. National and state estimates of lost earnings from cancer deaths in the United States. JAMA Oncol. 2019; 5 (9):e191460-e191460.
Kakushadze Z, Raghubanshi R, Yu W, Estimating cost savings from early cancer diagnosis. Data, 2017; 2(30): 2-16
Kim SY, Kim HS, Park HJ. Adverse events related to colonoscopy: global trends and future challenges, World J Gastroenterol. 2019; 25(2):190-204.
Losina E, Walensky RP, Geller A, Beddingfield FC, Wolf LL, Gilchrest BA, Freedberg KA, Visual Screening for Malignant Melanoma Cost-effectiveness Analysis, Arch Dermatol. 2007;143(1):21-28.
Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Clin Liver Dis (Hoboken). 2019;13(1):
MDSave, Mammogram Screening, 2020
Mayo Clinic Staff, PSA Test, Mayo Clinic Report, May 4, 2019
National Cancer Institute. Cancer screening. Updated April 9, 2018.
National Cancer Institute. Financial burden of cancer care. March 2020.
O’Connell A (2015) Mammograms: Facts on False Positives, Health Matters
Parkinson R, Ramsey S, Aitchinson M, Kumar M, Parsons K. Letters in response to Turney et al 2006. BJU Int (2006) 97:1121–4
Patel N, Cranston D, Akhtar MZ, George C, Jones A, Leiblich A, Protheroe A, Sullivan M, Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy BJU Int. 2012 Nov; 110(9):1270-5
Piepkorn M, Elmore J, Most mole biopsies are benign, says text analysis of EMRs, UW Medicine, Retrieved January 19, 2021.
Ran T, Cheng C-Y, Misselwitz B, Brenner H, Ubels J, Schlander M. Cost-effectiveness of colorectal cancer screening strategies—a systematic review. Clin Gastroenterol Hepatol. 2019;17 (10):1969-1981.
Rosenberg, J, Prostate Cancer in Older Men Costs Medicare $1.2 Billion Over 3-Year Period, AJMC, 2018
Sand B, Are all colon polyps precancerous or worse? Honor Health, 2020
Shrime MG, Goldstein MD, Seaberg RM, Sawka AM, Rotstein L, Freeman JL, Gullane PJ, Cost-effective Management of Low-Risk Papillary Thyroid Carcinoma, Arch Otolaryngol Head Neck Surg. 2007;133(12):1245-1253.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7-30.
Subramanian S, Tangka FK, Hoover S, Cole-Beebe M, Joseph D, DeGroff A. Comparison of Program Resources Required for Colonoscopy and Fecal Screening: Findings from 5 Years of the Colorectal Cancer Control Program. Prev Chronic Dis 2019,16:180338
US Preventive Services Task Force. A and B recommendations. 2020.
Ward KK, Shah NR, Saenz CC, et al.: Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol , 2012, 126 (2): 176-9
WebMD, Understanding Colorectal Cancer -- The Basics, WebMD.com, 2021
WebMD, Should I delay treatment for B-Cell Lymphoma, WebMD, on July 01, 2020
World Health Organization. Guide to cancer early diagnosis. 2017.
Yu J, Blackford AL, dal Molin M, et al, Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages, Gut 2015;64:1783-1789.
Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016; 5 (3):288-300.
